Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity Study Comparing Flucelvax and Flublok Influenza Vaccines in Adults
NCT06518577Phase 4Completed
- Sponsor
- Duke University
- Start
- Sep 2024
- Primary completion
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent, influenza vaccine in influenza, sponsored by Duke University. Started Sep 2024; status: completed.
02
Drugs
Fluzone Trivalentinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06518577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06518577.